|
Session 135
Poster Abstracts
Treatment Issues in Tuberculosis and HIV Co-Infection
Wednesday, 1:30 - 3:30 pm
Poster Hall |
792
 |
Tuberculin Skin Test Conversion among HIV-infected Individuals and Couples in MTCT-Plus Programs, Thailand
T Apornpong1, N Phanuphak1, S Teeratakulpisarn1, S Limpongsanurak2, W Luesomboon3, A Tangsathapornpong4, C Vitavasiri5, N Singhakowinta6, E Abrams7, Praphan Phanuphak*1, and MTCT-Plus Thailand
1Thai Red Cross AIDS Res Ctr, Bangkok; 2King Chulaonngkorn Memorial Hosp, Bangkok, Thailand; 3Queen Sawangwattana Memorial Hosp, Chonburi, Thailand; 4Thammasat Univ Hosp, Bangkok, Thailand; 5Police General Hosp, Bangkok, Thailand; 6Queen Sirikit hosp, Chonburi, Thailand; and 7Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US |
| 793 |
Use of Direct Amplification Techniques in HIV-infected Patients with Smear-negative Culture Proven Pulmonary Tuberculosis
C Defrance, S Dewit*, R Scheen, A Dediste, B Poll, and N Clumeck
St Pierre Univ Hosp, Brussels, Belgium |
| 794 |
Prevalence, Incidence, and Outcomes of Tuberculosis Treatment in HIV+ Individuals Initiating Home-based ART in Rural Uganda
David Moore*1,2, P Ekwaru1, C Liechty1,3, W Were1, G Mwima1, P Solberg1,4, and J Mermin1
1Global AIDS Prgm, CDC, Entebbe, Uganda; 2BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; 3Glen Cove Internal Med, Rockport, ME, US; and 4Dartmouth Univ Sch of Med, NH, US |
| 795 |
Identification of a Multi-drug-resistant Tuberculosis Cluster as a Cause of Death among HIV-co-infected Patients in Rural South Africa
A Moll1, Neel Gandhi*2,3, R Pawinski4, J Andrews2, K Zeller2,5, U Lalloo4, W Sturm4, and G Friedland2
1Church of Scotland Hosp & Philanjalo, Tugela Ferry, South Africa; 2Yale Univ, New Haven, CT, US; 3Emory Univ, Atlanta, GA, US; 4Nelson R Mandela Sch of Med, Durban, South Africa; and 5Brown Univ, Providence, RI, US |
796
|
A Randomized Trial of Early vs Delayed Fixed-dose Combination Zidovudine/Lamivudine/Abacavir in Patients Co-infected with HIV and Tuberculosis: Early Findings of the Tuberculosis and HIV Immune Reconstitution Syndrome Trial
Humphrey Shao*1,2, J Crump1,3, H Ramadhani1,2, L Uiso4, O Sendui-Nguyaine1,2, R Kiwera5, E Ndosi1, J Shao1,2, J Bartlett3, and N Thielman3
1Kilimanjaro Christian Med Ctr, Moshi, Tanzania; 2Kilimanjaro Christian Med Coll, Tumaini Univ, Moshi, Tanzania; 3Duke Univ Med Ctr, Durham, NC, US; 4Kibong’oto Natl Tuberculosis Hosp, Sanya Juu, Tanzania; and 5Kikundi cha Wanawake Kilimanjaro cha Kupambana na Ukimwi, Moshi, Tanzania |
797
|
Explosion of Tuberculin-specific CD4 Th1 Responses Induces Immune Restoration Syndrome in Tuberculosis and HIV Co-infected Patients
Anne Bourgarit*1,2, G Carcelain2, V Martinez2, C Lascoux-Combe1, M Lafaurie1, B Gicquel3, E Vicaut4, P H Lagrange1, D Sereni1, and B Autran2
1Hosp St Louis, Paris, France; 2INSERM U543, Univ Pierre et Marie Curie, Hosp Pitie-Salpetriere, Paris, France; 3Inst Pasteur, Paris, France; and 4Fernand Widal Hosp Paris, France |
| 798 |
Elevated HIV Seroprevalence and Risk Behaviors among TB Suspects in Uganda: Implications for HIV Transmission and Testing
Padmini Srikantiah*1, R Lin1, M Walusimbi2, A Okwera2, H Luzze2, C Whalen3, W Boom3, D Havlir1, and E Charlebois1
1Univ of California, San Francisco, US; 2Natl Tuberculosis and Leprosy Prgm, Kampala, Uganda; and 3Case Western Reserve Univ, Cleveland, OH, US |
| 799 |
Factors Associated with Positive Tuberculin Skin Test and the Results of Scaling up Tuberculosis Prevention among HIV- infected Clients of the Thai Red Cross Voluntary Counseling and Testing Centre, the Anonymous Clinic
Somsamorn Mangclaviraj*, S Paksin, P Suttapintu, P Suwanmala, S Chaitiamras, A Avihingsanon, S Tuntipaiboonvut, and P Phanuphak
Thai Red Cross AIDS Res Ctr, Bangkok |
|
